Daroui, Parima

TitleAssociate Clinical Professor
InstitutionUniversity of California, Irvine
DepartmentRadiation Oncology
Address1001 Health Sciences Road
CA 92697-3950
Phone(714) 456-7105
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Vuong W, Garg R, Bourgeois DJ, Yu S, Sehgal V, Daroui P. Dosimetric comparison of deep-inspiration breath-hold and free-breathing treatment delivery techniques for left-sided breast cancer using 3D surface tracking. Med Dosim. 2018 Aug 02. PMID: 30078605.
      View in: PubMed
    2. Sindhu K, Armstrong W, Hasso A, Farzaneh T, Daroui P. Recurrent squamous cell carcinoma involving cranial nerves in a patient with left glottic carcinoma treated with definitive radiation therapy: A case report. Pract Radiat Oncol. 2017 Mar - Apr; 7(2):100-102. PMID: 28274392.
      View in: PubMed
    3. Yu S, Sehgal V, Al-Ghazi M, Lawrenson L, Wei R, Kuo J, Daroui P, Ramsinghani N. Response to Letter to the Editor: Regarding "The dosimetric impact of image guided radiation therapy by intratumoral fiducial markers". Pract Radiat Oncol. 2017 Jan - Feb; 7(1):e87. PMID: 27889537.
      View in: PubMed
    4. Connor M, Wei RL, Yu S, Sehgal V, Klempner SJ, Daroui P. Radiation dermatitis caused by a bolus effect from an abdominal compression device. Med Dosim. 2016; 41(3):221-4. PMID: 27264694.
      View in: PubMed
    5. Yu S, Lawrenson L, Wei R, Sehgal V, Hanna N, Kuo J, Daroui P, Ramsinghani N, Al-Ghazi M. The dosimetric impact of image guided radiation therapy by intratumoral fiducial markers. Pract Radiat Oncol. 2016 Jul-Aug; 6(4):276-83. PMID: 26852174.
      View in: PubMed
    6. Daroui P, Jabbour SK, Herman JM, Abdel-Wahab M, Azad N, Blackstock AW, Das P, Goodman KA, Hong TS, Jones WE, Kaur H, Konski AA, Koong AC, Kumar R, Pawlik TM, Small W, Thomas CR, Suh WW. ACR Appropriateness Criteria® Resectable Stomach Cancer. Oncology (Williston Park). 2015 Aug; 29(8):595-602, C3. PMID: 26281845.
      View in: PubMed
    7. Mayadev J, Einck J, Elson S, Rugo H, Hwang S, Bold R, Daroui P, McCloskey S, Yashar C, Kim D, Fowble B. Practice patterns in the delivery of radiation therapy after mastectomy among the University of California Athena Breast Health Network. Clin Breast Cancer. 2015 Feb; 15(1):43-7. PMID: 25245425.
      View in: PubMed
    8. Goyal S, Daroui P, Khan AJ, Kearney T, Kirstein L, Haffty BG. Three-year outcomes of a once daily fractionation scheme for accelerated partial breast irradiation (APBI) using 3-D conformal radiotherapy (3D-CRT). Cancer Med. 2013 Dec; 2(6):964-71. PMID: 24403270; PMCID: PMC3892401.
    9. Daroui P, Gabel M, Khan AJ, Haffty BG, Goyal S. Utilization of breast conserving therapy in stages 0, I, and II breast cancer patients in New Jersey: an American College of Surgeons National Cancer Data Base (NCDB) analysis. Am J Clin Oncol. 2012 Apr; 35(2):130-5. PMID: 21325935.
      View in: PubMed
    10. Jabbour SK, Daroui P, Moore D, Licitra E, Gabel M, Aisner J. A novel paradigm in the treatment of oligometastatic non-small cell lung cancer. J Thorac Dis. 2011 Mar; 3(1):4-9. PMID: 22263057; PMCID: PMC3256496.
    11. Daroui P, Desai SD, Li TK, Liu AA, Liu LF. Hydrogen peroxide induces topoisomerase I-mediated DNA damage and cell death. J Biol Chem. 2004 Apr 09; 279(15):14587-94. PMID: 14688260.
      View in: PubMed
    12. Li TK, Houghton PJ, Desai SD, Daroui P, Liu AA, Hars ES, Ruchelman AL, LaVoie EJ, Liu LF. Characterization of ARC-111 as a novel topoisomerase I-targeting anticancer drug. Cancer Res. 2003 Dec 01; 63(23):8400-7. PMID: 14679002.
      View in: PubMed